ICVX Executive Compensation

* In USD (Original Currency)
Filing Date
(SEC Report)
Year Reporting Name Salary Bonus Stock Award Incentive Plan Compensation Other Compensation Total
2023-04-19 2022 Dr. Kanesa-thasan Chief Medical Officer 465,000 0 341,962 167,400 9,150 2,223,992
2023-04-19 2022 Adam Simpson Chief Executive Officer 580,000 0 1,326,394 266,800 9,150 6,906,391
2023-04-19 2021 Adam Simpson Chief Executive Officer 506,818 0 3,106,250 343,750 8,700 17,811,989
2023-04-19 2022 Dr. Cassia Cearley Chief Business Officer 445,000 0 377,043 178,000 9,150 2,378,540
2022-04-25 2021 Adam Simpson Chief Executive Officer and Director 506,818 0 3,106,250 343,750 8,700 17,811,989
2022-04-25 2020 Adam Simpson Chief Executive Officer and Director 357,291 0 0 144,703 0 623,287
2022-04-25 2021 Thomas Russo Chief Financial Officer 234,318 0 807,625 117,400 6,246 5,595,963
2022-04-25 2021 Elizabeth Bekiroglu General Counsel 119,318 50,000 1,098,900 58,600 2,819 7,807,636

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.